User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning.

Primary tabs

Balligand, Jean-Luc [UCL]
Document type Article de périodique (Journal article) – Éditorial
Access type Accès restreint
Publication date 2017
Language Anglais
Journal information "European Journal of Heart Failure" - Vol. 19, no. 4, p. 576-578 (2017)
Peer reviewed yes
Publisher Wiley ((United Kingdom) Chichester)
issn 1388-9842
e-issn 1879-0844
Publication status Publié
Affiliations UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique
UCL - (SLuc) Service de médecine interne et maladies infectieuses (MIMI)
Links
  1. Bundgaard, Eur J Heart Fail (2017)
  2. Moniotte S., Kobzik L., Feron O., Trochu J.-N., Gauthier C., Balligand J.-L., Upregulation of  3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium, 10.1161/01.cir.103.12.1649
  3. Vij Monika, Drake Marcus J., Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome, 10.1177/1756287215591763
  4. Liggett S. B., Freedman N. J., Schwinn D. A., Lefkowitz R. J., Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor., 10.1073/pnas.90.8.3665
  5. Gauthier C, Leblais V, Kobzik L, Trochu J N, Khandoudi N, Bril A, Balligand J L, Le Marec H, The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle., 10.1172/jci2191
  6. TAVERNIER G, TOUMANIANTZ G, ERFANIAN M, HEYMANN M, LAURENT K, LANGIN D, GAUTHIER C, ?-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human ?-adrenergic receptor, 10.1016/s0008-6363(03)00359-6
  7. Bundgaard H., Liu C.-C., Garcia A., Hamilton E. J., Huang Y., Chia K. K. M., Hunyor S. N., Figtree G. A., Rasmussen H. H.,  3 Adrenergic Stimulation of the Cardiac Na+-K+ Pump by Reversal of an Inhibitory Oxidative Modification, 10.1161/circulationaha.110.964619
  8. Masutani S., Cheng H.-J., Morimoto A., Hasegawa H., Han Q.-H., Little W. C., Cheng C. P.,  3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure, 10.1152/ajpheart.00371.2012
  9. Belge C., Hammond J., Dubois-Deruy E., Manoury B., Hamelet J., Beauloye C., Markl A., Pouleur A.-C., Bertrand L., Esfahani H., Jnaoui K., Gotz K. R., Nikolaev V. O., Vanderper A., Herijgers P., Lobysheva I., Iaccarino G., Hilfiker-Kleiner D., Tavernier G., Langin D., Dessy C., Balligand J.-L., Enhanced Expression of  3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling Through Nitric Oxide Synthase, 10.1161/circulationaha.113.004940
  10. Hammond Joanna, Balligand Jean-Luc, Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: From contractility to remodeling, 10.1016/j.yjmcc.2011.07.029
  11. Chia Karin K. M., Liu Chia-Chi, Hamilton Elisha J., Garcia Alvaro, Fry Natasha A., Hannam William, Figtree Gemma A., Rasmussen Helge H., Stimulation of the cardiac myocyte Na+-K+pump due to reversal of its constitutive oxidative inhibition, 10.1152/ajpcell.00392.2014
  12. Yancy C. W., Jessup M., Bozkurt B., Butler J., Casey D. E., Drazner M. H., Fonarow G. C., Geraci S. A., Horwich T., Januzzi J. L., Johnson M. R., Kasper E. K., Levy W. C., Masoudi F. A., McBride P. E., McMurray J. J. V., Mitchell J. E., Peterson P. N., Riegel B., Sam F., Stevenson L. W., Tang W. H. W., Tsai E. J., Wilkoff B. L., 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 10.1161/cir.0b013e31829e8807
  13. Dessy C., Endothelial  3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization, 10.1161/01.cir.0000139331.85766.af
  14. Maier Lars S, A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine : , 10.1097/fjc.0b013e3181a1b9e7
  15. Trappanese Danielle M., Liu Yuchuan, McCormick Ryan C., Cannavo Alessandro, Nanayakkara Gayani, Baskharoun Marina M., Jarrett Harish, Woitek Felix J., Tillson D. Michael, Dillon A. Ray, Recchia Fabio A., Balligand Jean-Luc, Houser Steven R., Koch Walter J., Dell’Italia Louis J., Tsai Emily J., Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy, 10.1007/s00395-014-0456-3
  16. Balligand Jean-Luc, Cardiac salvage by tweaking with beta-3-adrenergic receptors, 10.1093/cvr/cvw056
Bibliographic reference Balligand, Jean-Luc. Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning.. In: European Journal of Heart Failure, Vol. 19, no. 4, p. 576-578 (2017)
Permanent URL http://hdl.handle.net/2078.1/183474